Passage BIO, Inc. (PASG) stock

PASGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30

$4.25+0.24 (+5.99%)

Close on Nov 13, 2026Market cap $13.68MP/E –Yield –

Passage BIO gross margin

Gross margin is gross profit as a percentage of revenue.

Passage BIO has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?